News & Insights

Article

November 20, 2020 - Source: Food and Drug Law Institute

That Will Leave a Mark: FDA’s Shifting Approach to Regulating the Coronavirus Testing Market Creates Confusion, Opportunities, and Enforcement Risk


Go to the article